id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
fnp-9165	The Canadian Association of Neuropathologists - Association canadienne des neuropathologistes (CANP-ACNP)	65th Annual Meeting of the Canadian Association of Neuropathologists - Association canadienne des neuropathologistes (CANP-ACNP)	2025		.htm	application/xhtml+xml	8210	256	21	Abstract 6 Free Neuropathol 6:23:9 Cognitive subtyping in schizophrenia reveals distinct clinicopathologic signatures and a vascular-linked cognitive phenotype Naomi C. Futhey1–3, Fidel Vila-Rodriguez4,5, Shawn J. Stochmanski4, Elizabeth Gregory4, William Honer4, Belen Arranz6,7, Belen Ramos6–8, Ana Escanilla6, America Vera-Montecinos8,9, Mark S. Cembrowski1,2,5,10, Veronica Hirsch-Reinshagen3 Djavad Mowafaghian Centre for Brain Health, University of British Columbia, Vancouver, Canada Department of Cellular; Physiological Sciences, Faculty of Medicine, University of British Columbia, Vancouver, Canada Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada Department of Psychiatry, University of British Columbia, Vancouver, Canada School of Biomedical Engineering, University of British Columbia, Vancouver, Canada Parc Sanitari Sant Joan de Déu, Dr. Antoni Pujadas, Sant Boi de Llobregat, Spain Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM (Biomedical Network Research Center of Mental Health), Ministry of Economy, Industry and Competitiveness Institute of Health Carlos III, Madrid, Spain Psiquiatria Molecular, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain Departamento de Ciencias Biológicas y Químicas, Facultad De Ciencias, Universidad San Sebastián, Sede Tres Pascualas Lientur 1457, Concepción, Chile Department of Mathematics, University of British Columbia, Vancouver, Canada Cognitive impairment is a defining feature of chronic schizophrenia, but its underlying neuropathology remains unclear and treatment options are scarce. Thus, an inexpensive and time-efficient assay for detecting CDKN2A/B HD would be helpful for routine neuropathology cases.	cache/fnp-9165.htm	txt/fnp-9165.txt